GTR 115579988
Tenders Are Invited For Pharmaceutical Products – Belantamab Mafodotin As Part Of The Implementation Of The B.54 Drug Program Treatment Of Patients With Multiple Myeloma - 1 Assortment Package
ICB — International Competitive Bid
Closes Aug 21, 2026
central europe
Tender Information
GTR Reference
115579988
Tendering Authority
Subscribe to view
Tender No
480494-2026
Financer Name
Self-Funded
Work Title
Tenders Are Invited For Pharmaceutical Products – Belantamab Mafodotin As Part Of The Implementation Of The B.54 Drug Program Treatment Of Patients With Multiple Myeloma - 1 Assortment Package
Bid Type
ICB — International Competitive Bid
Country
Subscribe to view
Geographical Region
central europe
Political Region
European Union
Last Date of Bid Submission
21-08-2026
Work Detail
Pharmaceutical Products – Belantamab Mafodotin As Part Of The Implementation Of The B.54 Drug Program Treatment Of Patients With Multiple Myeloma - 1 Assortment Package. Belantamab Mafodotin
Key Value
Tender Value
Ref. Document
Tender Documents
Global Tender Document
1cb853dc-331a-4825-ab56-22afacf047fe.html
Attachments
Additional Details Available on Click
- Tendering Authority
- Publication Document (Tender Document / Tender Notice)
Disclaimer
We take all possible care for accurate & authentic tender information. However, users are requested to refer to the original Tender Notice / Tender Document published by the Tender Issuing Agency before taking any decision regarding this tender.